AZ sells rights to three older drugs to Covis for $350mAstraZeneca has agreed to sell rights to three older drugs for asthma and rhinitis to Covis Pharma for Share XAZ sells rights to three older drugs to Covis for $350mhttps://pharmaphorum.com/news/az-sells-rights-to-three-older-drugs-to-covis-for-350m/
